200 related articles for article (PubMed ID: 32109431)
1. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma.
Bartolini D; Dallaglio K; Torquato P; Piroddi M; Galli F
Transl Res; 2018 Mar; 193():54-71. PubMed ID: 29274776
[TBL] [Abstract][Full Text] [Related]
3. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
[TBL] [Abstract][Full Text] [Related]
5. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
[TBL] [Abstract][Full Text] [Related]
6. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
Tian B; Lu ZN; Guo XL
Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
[TBL] [Abstract][Full Text] [Related]
7. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
[TBL] [Abstract][Full Text] [Related]
9. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.
Kudo Y; Sugimoto M; Arias E; Kasashima H; Cordes T; Linares JF; Duran A; Nakanishi Y; Nakanishi N; L'Hermitte A; Campos A; Senni N; Rooslid T; Roberts LR; Cuervo AM; Metallo CM; Karin M; Diaz-Meco MT; Moscat J
Cancer Cell; 2020 Aug; 38(2):247-262.e11. PubMed ID: 32589943
[TBL] [Abstract][Full Text] [Related]
10. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
11. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
Ichimura Y; Waguri S; Sou YS; Kageyama S; Hasegawa J; Ishimura R; Saito T; Yang Y; Kouno T; Fukutomi T; Hoshii T; Hirao A; Takagi K; Mizushima T; Motohashi H; Lee MS; Yoshimori T; Tanaka K; Yamamoto M; Komatsu M
Mol Cell; 2013 Sep; 51(5):618-31. PubMed ID: 24011591
[TBL] [Abstract][Full Text] [Related]
13. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
[TBL] [Abstract][Full Text] [Related]
14. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.
Cho JH; Lee YM; Bae SH; Chou JY
Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334
[TBL] [Abstract][Full Text] [Related]
15. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV suppresses migration and invasion of TGF-β
Li L; Wang Q; He Y; Sun L; Yang Y; Pang X
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):397-405. PubMed ID: 35092472
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB.
Al-Gayyar MMH; Bagalagel A; Noor AO; Almasri DM; Diri R
Biomed Pharmacother; 2019 Apr; 112():108653. PubMed ID: 30784932
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
[TBL] [Abstract][Full Text] [Related]
20. Fine particulate matter (PM
Li J; Jiang H; Zhu Y; Ma Z; Li B; Dong J; Xiao C; Hu A
Ecotoxicol Environ Saf; 2024 Mar; 272():116052. PubMed ID: 38325274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
